New Insights into Diseases with Cognitive Impairment: Development, Genesis, and Treatment

Dear Colleagues,

The enormous impact of cognitive impairment in all its forms from mild cognitive impairment to dementia has become a public health concern from many perspectives and one that requires action from many sectors. It is increasingly important to fully understand the neurocognitive changes related not only to aging or neurological disorders at all ages, but also to systemic diseases that affect cognitive functions such as endocrine, metabolic, hepatic, and renal diseases.

Research on cognitive functions deals with language, learning, memory and other intellectual capacities responsible for daily adaptation, as well as explaining the mechanism of cognitive changes that occur in different disorders and diseases. Research on cognitive impairment is currently focused on the identification of risk factors and the mechanism of impairment and pharmacological and non-pharmacological treatments to prevent or delay cognitive decline. The aim of this Special Issue is to provide an overview of the latest advances and to present some comprehensive reviews on specific aspects of cognitive impairment.

In particular, of great interest are the presentation and examination of patterns of cognitive impairment observed in various neurological, psychiatric and other diseases that although affect organs and tissues outside the central nervous system may affect cognitive functions as well. Several studies on molecular mechanisms and pathophysiology as well as methods for the accurate diagnosis of cognitive impairment, such as neuropsychometric tests, blood tests, neuroimaging techniques and clinical neurophysiology, may be relevant to this Special Issue. Finally, the advancement of treatments for cognitive impairment or its prevention is particularly in demand. We welcome contributions in the form of original research articles, reviews and communications.

This Special Issue in Biomedicines, Diseases and Pathophysiology will focus on current advances in the study of cognitive impairment, providing a forum and open access opportunity to publish research papers in this exciting and necessary area of research.

You may choose our Joint Special Issue in Diseases and our Joint Special Issue in Biomolecules.

Dr. Omar Cauli
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathophysiology is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• dementia
• brain
• biomarkers